Voyager Therapeutics, Inc.·4

Apr 12, 4:01 PM ET

Ravina Bernard 4

4 · Voyager Therapeutics, Inc. · Filed Apr 12, 2018

Insider Transaction Report

Form 4
Period: 2018-04-10
Ravina Bernard
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2018-04-10$18.38/sh2,451$45,0490 total
Footnotes (2)
  • [F1]The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.04 to $18.61, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Documents

1 file
  • 4
    a4.xmlPrimary

    4